UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. Application to an individual treated with medical cannabis

THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of “light cannabis”

(2020) Roberta Pacifici et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Is “light cannabis” really light? Determination of cannabinoids content in commercial products

(2020) Emilia Marchei et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Herbal Preparations of Medical Cannabis: A Vademecum for Prescribing Doctors

(2020) Pietro Brunetti et al.   Medicina-Lithuania

Cannabidiol Adverse Effects and Toxicity

(2019) Marilyn A. Huestis et al.   Current Neuropharmacology

Fast and sensitive UHPLC-MS/MS analysis of cannabinoids and their acid precursors in pharmaceutical preparations of medical cannabis and their metabolites in conventional and non-conventional biological matrices of treated individual

(2019) Simona Pichini et al.   TALANTA

Evaluation of long-term stability of cannabinoids in standardized preparations of cannabis flowering tops and cannabis oil by ultra-high-performance liquid chromatography tandem mass spectrometry

(2018) Roberta Pacifici et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Stability of cannabinoids in cannabis FM1 flowering tops and oil preparation evaluated by ultra-high performance liquid chromatography tandem mass spectrometry

(2018) Roberta Pacifici et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine

(2013) Mateus M. Bergamaschi et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects

(2011) Ethan B Russo   BRITISH JOURNAL OF PHARMACOLOGY